Yoshimi Shimizu
Tokyo, 1628640, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Allosteric targeting of the ACE2 dimer interface by a medium-sized compound inhibits SARS-CoV-2 entry.
Journal: Journal of molecular biology
Published: February 11, 2026
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne.
Journal: Biological & pharmaceutical bulletin
Published: May 01, 2024
Synthesis and in Vitro Cytotoxicity Evaluation of Jadomycins.
Journal: Chemical & pharmaceutical bulletin
Published: September 04, 2023
Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid.
Journal: International journal of molecular sciences
Published: November 09, 2022
The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione.
Journal: Biochemical and biophysical research communications
Published: January 18, 2022
Anti-tumor effect of a recombinant Bifidobacterium strain secreting a claudin-targeting molecule in a mouse breast cancer model.
Journal: European journal of pharmacology
Published: April 25, 2020
Toxicity of Gold Nanoparticles in Mice due to Nanoparticle/Drug Interaction Induces Acute Kidney Damage.
Journal: Nanoscale research letters
Published: March 26, 2020
Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection.
Journal: Biochemical and biophysical research communications
Published: April 18, 2019
Last Updated: 09/26/2026